# Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.

> **NCT06929910** · — · RECRUITING · sponsor: **Gene Solutions** · enrollment: 200 (estimated)

## Conditions studied

- Metastatic Cancers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06929910
- **Lead sponsor:** Gene Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-09
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06929910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06929910, "Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06929910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*